Pre-referral rectal artesunate is no “magic bullet” in weak health systems
Abstract Severe malaria is a potentially fatal condition that requires urgent treatment. In a clinical trial, a sub-group of children treated with rectal artesunate (RAS) before being referred to a health facility had an increased chance of survival. We recently published in BMC Medicine results of...
Main Authors: | Manuel W. Hetzel, Jean Okitawutshu, Antoinette Tshefu, Elizabeth Omoluabi, Phyllis Awor, Aita Signorell, Marek Kwiatkowski, Mark J. Lambiris, Theodoor Visser, Justin M. Cohen, Valentina Buj, Christian Burri, Christian Lengeler |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2023-03-01
|
Series: | BMC Medicine |
Subjects: | |
Online Access: | https://doi.org/10.1186/s12916-023-02777-y |
Similar Items
-
Key factors predicting suspected severe malaria case management and health outcomes: an operational study in the Democratic Republic of the Congo
by: Jean Okitawutshu, et al.
Published: (2022-09-01) -
Effectiveness of rectal artesunate as pre-referral treatment for severe malaria in children under 5 years of age: a multi-country observational study
by: Manuel W. Hetzel, et al.
Published: (2022-10-01) -
Assessing caregivers’ perceptions of treatment-seeking for suspected severe malaria in the Democratic Republic of the Congo
by: Jean Okitawutshu, et al.
Published: (2023-10-01) -
Tratamento da malária com artesunate (retocaps®) em crianças da Amazônia brasileira Malaria treatment with artesunate (retocaps®) in children of the Brazilian Amazon
by: Maria das Graças Costa Alecrim, et al.
Published: (2000-04-01) -
Post‐Artesunate Delayed Hemolysis: Anything That Can Go Wrong Will Go Wrong—Murphy's Law
by: Beliza Chemutai, et al.
Published: (2025-01-01)